The human body is an extremely complex molecular machine, the details of which can be followed through certain substances; so-called biomarkers. Unfortunately, it is not yet possible to monitor biomarkers live in patients when these are present in minuscule concentrations. Researchers at Eindhoven University of Technology have now developed a new technique that can become the plain and simple solution for the live and super-sensitive monitoring of biomarkers.
They report on it in Nature Communications.
Substances that are essential for the body, such as proteins and hormones, are present in the blood in pico- or nanomolar concentrations. These are concentrations comparable to 1 sugar grain dissolved in an Olympic-sized swimming pool – extremely low, and difficult to measure. In the Molecular Biosensing for Medical Diagnostics group at Eindhoven University of Technology, under the guidance of Professor Menno Prins, a sensing technology has been developed that enables the super-sensitive measurement of biomarker concentrations over time.
The technique is based on the fact that tiny particles in liquid are continuously in Brownian motion because water molecules collide with them. The researchers bound the particles through a nanostrand to a glass plate, causing the particles to wiggle back and forth. The biomarker to be measured binds temporarily to specific adhesive molecules that are fixed to both the particles and the plate. When a biomarker molecule attaches itself to both a wiggling particle and to the plate, the particle suddenly becomes attached, which greatly reduces its mobility – until the biomarker is released again.
The mobility of the particles, which are coupled to the transparent glass, could be easily observed by the researchers with light. They have given their technology the name BPM: Biomarker monitoring based on sensing of Particle Mobility. Every time a wiggling particle suddenly moves less, and then more, one biomarker molecule has been observed. The number of these events per minute reveals the concentration of the biomarker in the liquid with a high degree of sensitivity.
The principle is explained in this animation video: https:/
The beauty of the BPM sensor technology is that it has digital precision, and that both increases and decreases in biomarker concentration over time can be monitored. The technique has now been demonstrated for the monitoring of protein and DNA. The technology is widely applicable, because suitable adhesion molecules are available for almost all biomarkers.
This flexibility, combined with the sensitivity and the expected miniaturization of the technology, means that Prins and his fellow researchers have high expectations of the future for their technology. “We anticipate that a completely new class of sensors for the monitoring of biomarkers will emerge from this,” says the professor, so he is creating a start-up that will develop practical sensors and applications. One of the possibilities is to connect a sensor to a catheter with which patients in the operating room or in the intensive care unit can be accurately monitored. In addition to medical applications, Prins also thinks there are possibilities for monitoring biomolecules in industrial processes and water purification.
Receive an email update when we add a new BIOMARKERS article.
The Latest on: Monitoring of biomarkers
via Google News
The Latest on: Monitoring of biomarkers
- Hyaluronic Acid Products Market Rising Number of Applications to Accelerate Market Growth on November 12, 2018 at 11:13 am
In recent years, the molecule have been used as a biomarker for various cancer types, especially that of prostate and breast. In addition, they can help in monitoring the disease progression. Since th... […]
- Data released at The Liver Meeting ® 2018 Shows MRCP+ is a Promising Non-Invasive Technology for Quantitative Evaluation of Hepatobiliary Diseases on November 12, 2018 at 9:03 am
(Logo: https://mma.prnewswire.com/media/352708/perspectum_diagnostics_Logo.jpg) Accurate assessment of the biliary system is essential in diagnosis and monitoring of hepatobiliary diseases like ... […]
- Brain activity monitoring reveals a potential biomarker for depression on November 8, 2018 at 10:41 pm
The research was carried out by neuroscientists at the University of California, San Francisco, and involved monitoring the ... such a powerfully informative biomarker was more than what we ... […]
- NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing on November 8, 2018 at 3:32 am
The content is designed to investigate biomarkers for CAR-T characterization ... Director of the Hillman Immunologic Monitoring and Cellular Products Laboratory at the University of Pittsburgh, UPMC H... […]
- Olink Earns Acclaim from Frost & Sullivan for its Cardiac Protein Biomarker Multiplex Panels, CVD II and CVD III on November 6, 2018 at 11:23 am
Future health will be significantly improved using biomarkers for disease prediction, monitoring and, diagnosis of patients with a higher degree of precision, allowing patient to get the right treatme... […]
- DiamiR Announces Two Publications on microRNA Biomarkers and Mechanisms of Aging on November 5, 2018 at 11:30 am
"Aging is a major risk factor for many diseases. The development of reliable biomarkers for monitoring of aging should lead to a better understanding of aging-associated processes and facilitate the d... […]
- PolyU and University of Waterloo sign historic institutional agreement on November 5, 2018 at 7:39 am
The researchers will explore new approaches in the detection and treatment of eye diseases, study the use of tear fluid as biomarkers to predict and ... also research into early diagnosis and disease ... […]
- Onxeo Announces Positive Interim Results from Phase 1 Study of AsiDNATM, a First-In-Class DNA Damage Response Inhibitor on November 5, 2018 at 3:21 am
Furthermore, the quantification of a well-known tumor proliferation biomarker, Ki67, showed a clear decrease ... Each dose level is stepped up following validation by a Data Safety Monitoring Board. T... […]
- Jounce Therapeutics to Present Two Posters from the JTX-2011 Program at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting on November 1, 2018 at 10:48 pm
Biomarkers and Immune Monitoring Poster Session Number: 52 Location: Hall E Date and Time: Saturday, November 10, 2018; 12:20pm-1:50pm ET and 7:00pm-8:30pm ET Poster Title: Inducible T cell Co-stimula... […]
via Bing News